Orexigen Therapeutics, Inc. (OREX) Posts Q4 Loss of 9c/Share
Tweet Send to a FriendGet Alerts OREX Hot Sheet
Price: $6.33 -0.78%
EPS Growth %: -355.6%
Financial Fact:
Net loss per share: -0.21
Today's EPS Names:
CEDU, CHC, CIDM, More
EPS Growth %: -355.6%
Financial Fact:
Net loss per share: -0.21
Today's EPS Names:
CEDU, CHC, CIDM, More
Trade OREX Now!
Orexigen Therapeutics, Inc. (NASDAQ: OREX) reported Q4 EPS of ($0.09), $0.01 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $857 thousand versus the consensus estimate of $940 thousand.
For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Orexigen Therapeutics, Inc. (OREX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jabil Circuit (JBL) Tops Q3 EPS by 2c; Issues Light Q4 Outlook; Will Realign Global Ops
- American Medical Association Calls Obesity A Disease (ARNA) (VVUS)
- Fedex Corp. (FDX) Tops Q4 EPS by 17c, Sales Light
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
